Merck, Glenmark Cut Deal With Last Group Of Zetia Buyers
IP Law 360
APRIL 24, 2023
Drug companies Merck & Co. and Glenmark Pharmaceuticals on Monday settled with a group of retail pharmacies, narrowly avoiding a jury trial over allegations they conspired to keep a cheaper version of the cholesterol drug Zetia off the market more than two decades ago.
Let's personalize your content